Cell culture conditions affect the ability of high content imaging assay to detect drug-induced changes in cellular parameters in human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)

This publication has 13 references indexed in Scilit:

• Use of FDSS/μCell imaging platform for preclinical cardiac electrophysiology safety screening of compounds in human induced pluripotent stem cell-derived cardiomyocytes
  Journal of Pharmacological and Toxicological Methods, 2016
• Extracellular Matrix–Mediated Maturation of Human Pluripotent Stem Cell–Derived Cardiac Monolayer Structure and Electrophysiological Function
  Circulation: Arrhythmia and Electrophysiology, 2016
• High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes
  ASSAY and Drug Development Technologies, 2015
• Structural and functional screening in human induced-pluripotent stem cell-derived cardiomyocytes accurately identifies cardiotoxicity of multiple drug types
  Toxicology and Applied Pharmacology, 2015
• Refining the Human iPSC-Cardiomyocyte Arrhythmic Risk Assessment Model
  Toxicological Sciences, 2013
• Extracellular Matrix Promotes Highly Efficient Cardiac Differentiation of Human Pluripotent Stem Cells
  Circulation Research, 2012
• Dynamic monitoring of beating periodicity of stem cell‐derived cardiomyocytes as a predictive tool for preclinical safety assessment
  British Journal of Pharmacology, 2011
• Estimating the Risk of Drug-Induced Proarrhythmia Using Human Induced Pluripotent Stem Cell–Derived Cardiomyocytes
  Toxicological Sciences, 2011
• Long-term self-renewal of human pluripotent stem cells on human recombinant laminin-511
  Nature Biotechnology, 2010
• Receiver-Operating Characteristic Analysis for Evaluating Diagnostic Tests and Predictive Models
  Circulation, 2007